These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4053145)

  • 21. [Urapidil (Ebrantil) use in patients on chronic hemodialysis].
    Krawczyk W; Steć E
    Wiad Lek; 1990 Jun; 43(11):501-5. PubMed ID: 2219915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic effects of guanfacine in essential hypertension.
    Feldstein CA; Cohen AA; Sabaris RP; Burucúa JE
    Clin Ther; 1984; 6(3):325-34. PubMed ID: 6373009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Urapidil in primary arterial hypertension].
    Román O; Sudy E; Gac JC; Valenzuela MA
    Rev Med Chil; 1987 Jul; 115(7):648-54. PubMed ID: 3331026
    [No Abstract]   [Full Text] [Related]  

  • 27. [Long-term antihypertensive therapy with urapidil. A 3-year open, multicenter trial of tolerance, safety and effectiveness].
    Liebau H; Solleder P; Harder I; Wurst W
    Fortschr Med; 1990 May; 108(16):325-8. PubMed ID: 2118878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac morphology and function in arterial hypertension. The effects of a new multifactorial hypotensive agent: urapidil.
    Ghione S; Genovesi-Ebert A; Marabotti C; Spinazzi A; Noseda A
    Blood Press Suppl; 1994; 4():25-30. PubMed ID: 7804509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of once-daily urapidil treatment in mild or moderate essential hypertension assessed by ambulatory 24-hour blood pressure monitoring.
    Trimarco B; Rosiello G; Feldhaus P; Steinijans VW; Vecchione F; Cuocolo A; Lembo G; Volpe M
    Drugs; 1988; 35 Suppl 6():173-81. PubMed ID: 3402355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonidine twice daily in hypertension. Effects of two dosage regimens on blood pressure, side-effects and plasma clonidine concentrations.
    Lilja M; Huikuri H; Jounela AJ; Juustila HJ; Paalzow G
    Acta Med Scand; 1983; 214(2):111-7. PubMed ID: 6353878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The use of urapidil in the postoperative period].
    Puchstein C; Van Aken H; Zander J; Lawin P
    Anaesthesist; 1984 May; 33(5):224-7. PubMed ID: 6465511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antihypertensive action of various talinolol dosages after four week's treatment in comparison with placebo].
    Weigmann I; Terhaag B; Wierich W; Herrmann WM
    Arzneimittelforschung; 1998 Mar; 48(3):240-4. PubMed ID: 9553680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of hypertension with urapidil (Ebrantil)].
    Sirakova V; Penkov N; Kaponov Kh
    Vutr Boles; 1986; 25(2):29-32. PubMed ID: 2872754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of piretanide capsules on blood pressure during ergometric and isometric work loads in patients with mild to moderate essential hypertension.
    Meywald W; Maass L; Verho M; Rangoonwala B
    Pharmatherapeutica; 1985; 4(6):356-66. PubMed ID: 4080753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study on the effects of niludipine in hypertensive patients.
    Kuwajima I; Ueda K; Murakami M
    Arzneimittelforschung; 1982; 32(4):398-402. PubMed ID: 7201809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive effect of prizidilol.
    Jounela AJ; Honkala M; Huikuri H
    Ann Clin Res; 1984; 16(3):176-80. PubMed ID: 6383185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.